Viewing Study NCT01356303


Ignite Creation Date: 2025-12-24 @ 7:30 PM
Ignite Modification Date: 2025-12-25 @ 5:11 PM
Study NCT ID: NCT01356303
Status: SUSPENDED
Last Update Posted: 2016-05-13
First Post: 2011-03-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Docetaxel Combined With Cisplatin as First Line in Patients With Metastatic Non-small Cell Lung Cancer
Sponsor: National Guard Health Affairs
Organization:

Organization Data

Organization:
Class: OTHER_GOV
Study ID: RC08/068
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators